Tribe Stays | $2,800,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)
PowerLattice | $25,000,000 | (Nov 18, 2025)
Scripta Therapeutics
United Kingdom
- Oxford
- 18/11/2025
- Seed
- $12,000,000
Scripta Therapeutics is an Oxford-based techbio company that takes a biology-first approach to discover disease-modifying drugs that modulate transcription factor activity and reprogram biology.
We aim to discover and develop therapeutics for neurodegenerative disorders. We are following a unique strategy, based on the concept that transcription factors, the master controllers of gene expression, are core drivers of disease and act as detailed and dynamic maps of disease. Therapeutics that modulate these maps to restore the healthy cell state can be efficiently identified by a data-rich, lab-in-the-loop combination of experimental biology with cutting-edge AI and informatics.
- Industry Biotechnology Research
- Website https://www.scriptatherapeutics.com/
- LinkedIn https://www.linkedin.com/company/scripta-therapeutics/
Related People
Peter HamleyFounder
United Kingdom -
Oxford, England
With over 25 years of experience in the pharmaceutical and biotech industry, I have a strong background in life sciences, chemistry and biology, and a proven track record of delivering drugs into development and establishing new external business models in big pharma. Most recently, I have built and lead biotech start-ups developing novel therapies for aging-related diseases, focussing on neurodegeneration.
My mission is to leverage the latest advances in science and technology to discover and develop innovative solutions that can modify disease, extend healthspan and improve quality of life. I have led or participated in many strategic partnerships and collaborations with biotech, academia and pharma companies, as well as scientific advisory boards, to identify and build the best sources of innovation and expertise. I am passionate about building high technology teams and instilling a culture of excellence, creativity and collaboration.
Shipday | $7,000,000 | (Nov 18, 2025)
Muse Software | $4,500,000 | (Nov 18, 2025)
Artios | $115,000,000 | (Nov 18, 2025)
Self Labs | $9,000,000 | (Nov 18, 2025)
Obello | $8,500,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
Skeletalis, Inc. | $8,000,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)